For Immediate Release
Oak Brook, IL – The October issue of SLAS Technology features the cover article, “Role of Digital Microfluidics in Enabling Access to Laboratory Automation and Making Biology Programmable” by Varun B. Kothamachu, Ph.D., Sabrina Zaini and Federico Muffatto (Digi.Bio).
October’s cover article explores the role of digital microfluidics (DMF) as a “digital bioconverter” that brings together the digital aspects of the design-build-learn cycle with the physical nature of experimentation. The article also discusses the function of a DMF device and examines how DMF is limited by known technical and operational challenges and the key to overcoming these challenges.
Such challenges that face scientists are the associated costs and late-stage risk in developing microfluid technologies for the purpose of diagnosing and preventing bodily disorders, including haemostatic disorders, cancers and molecular abnormalities.
The latest issue includes six articles of original research, in addition to a technical brief, a methods and protocol article, and the featured cover article.
Original research articles include:
Other articles include:
Access to October’s SLAS Technology issue is available at https://journals.sagepub.com/toc/jlad/25/5 through November 20. For more information about SLAS and its journals, visit www.slas.org/publications/slas-technology/. Access a “behind the scenes” look at the latest issue with SLAS Technology Authors Talk Tech podcast. Tune in by visiting https://www.buzzsprout.com/1099523.
*****
SLAS (Society for Laboratory Automation and Screening) is an international community of 16,000 professionals and students dedicated to life sciences discovery and technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.
SLAS Discovery: Advancing the Science of Drug Discovery, 2019 Impact Factor 2.195. Editor-in-Chief Robert M. Campbell, Ph.D., Twentyeight-seven Therapeutics, Boston, MA (USA).
SLAS Technology: Translating Life Sciences Innovation, 2019 Impact Factor 2.174. Editor-in-Chief Edward Kai-Hua Chow, Ph.D., National University of Singapore (Singapore).
###
Jill Hronek
Director of Marketing Communications
Telephone: +1.630.256.7527, ext. 103
E-Mail: jhronek@slas.org